BIOCOAT (Biocompatible Innovative Orthopaedic implant based on lubricious COating Advanced Technologies)

BioCoat项目是一项技术可行性研究，旨在将现有的涂层工艺应用于一个新的领域，从一次性使用的医疗器械领域到长期植入领域。BioInteraction Ltd和Aurora Medical Ltd将共同打造开发新型微创植入物和程序所需的涂层技术块。这将提供一个具有成本效益的解决方案，特别是对于关节置换手术并发症发生率较高的老年虚弱患者组，并作为治疗关节炎疼痛的非类固醇抗炎药的替代药物。在人口老龄化和肥胖增加的背景下，以及全球医疗服务面临的经济压力，这种创新的植入物将在临床试验开始5年后，使NHS每年节省超过1.3亿GB的资金，并为全球医疗服务提供一种新颖、经济高效的解决方案。从长远来看，该项目开发的技术类型将为英国和欧洲提供强大的竞争优势。

The BIOCOAT project is a technical feasibility study to will allow the application of existinv coating processes to a new area, from the single use disposable medical device field to the long term implantation field. BioInteractions Ltd and Aurora Medical Ltd are coming togheter to build the coating technology block required to develop a novel, minimally invasive implant and procedure. This would provide a cost effective solution, in particular for the older frail patient group in which joint replacement operations have high complication rates, and as an alternative to NSAIDs for the treatement of arthritis pain. In the context of an ageing population and increasing obesity as well as the econmic pressure facing health services worldwide, the innovative implant would allow NHS savings of more than £130m per year 5 years after the start of the clincal trial, and offer a novel, cost effective solution to Health Services worldwide. In the longer term the type of technology developed inthis project will provide a strong competitive advantage to the UK and Europe.